Literature DB >> 8081065

Can we stop bone loss and prevent hip fractures in the elderly?

P J Meunier1, M C Chapuy, M E Arlot, P D Delmas, F Duboeuf.   

Abstract

The two main determinants of hip fractures are falls and bone loss leading to an intrinsic femoral fragility. Substantial femoral bone loss continues throughout old age, with a continuous and exponential increase in the risk of hip fracture; thus any reduction or arrest of this loss will induce an important reduction in the incidence of hip fracture. Preventive measures may be achieved during childhood by increasing peak bone mass with calcium and exercise, by using long-term estrogen replacement therapy after menopause, but also by using vitamin D and calcium supplements for late prevention in the elderly. Vitamin D insufficiency and a deficit in calcium intake are very common in the elderly living either in institutions or at home and the cumulative response to these deficits is a negative calcium balance which stimulates parathyroid hormone secretion. This senile secondary hyperparathyroidism is one of the determinants of femoral bone loss and can be reversed by calcium and vitamin D supplements. We have shown in a 3-year controlled prospective study that the daily use of supplements (1.2 g calcium and 800 IU vitamin D3) given in a large population of 3270 elderly ambulatory women living in nursing homes reduced the number of hip fractures by 23% (intention-to-treat analysis). In parallel, serum parathyroid hormone concentrations were reduced by 28% and low baseline serum 25-hydroxyvitamin D concentration returned to normal values. After 18 months of treatment the bone density of the total proximal femoral region had increased by 2.7% in the vitamin D3-calcium group and decreased by 4.6% in the placebo group (p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8081065     DOI: 10.1007/bf01623440

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  31 in total

1.  The effect of postmenopausal estrogen therapy on bone density in elderly women.

Authors:  D T Felson; Y Zhang; M T Hannan; D P Kiel; P W Wilson; J J Anderson
Journal:  N Engl J Med       Date:  1993-10-14       Impact factor: 91.245

2.  Evidence for two distinct syndromes of involutional osteoporosis.

Authors:  B L Riggs; L J Melton
Journal:  Am J Med       Date:  1983-12       Impact factor: 4.965

3.  Long-term estrogen replacement therapy prevents bone loss and fractures.

Authors:  B Ettinger; H K Genant; C E Cann
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

4.  Heterogeneity of fracture syndromes in postmenopausal women.

Authors:  C C Johnston; J Norton; M R Khairi; C Kernek; C Edouard; M Arlot; P J Meunier
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

5.  Secular increase and geographical differences in hip fracture incidence in Norway.

Authors:  J A Falch; T S Kaastad; G Bøhler; J Espeland; O J Sundsvold
Journal:  Bone       Date:  1993 Jul-Aug       Impact factor: 4.398

Review 6.  Bone remodeling in hip fracture.

Authors:  J Reeve; J M Zanelli; N Garrahan; J N Bradbeer; J S Wand; S T Moyes; J P Roux; T Smith
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

7.  Effect of external hip protectors on hip fractures.

Authors:  J B Lauritzen; M M Petersen; B Lund
Journal:  Lancet       Date:  1993-01-02       Impact factor: 79.321

8.  Effect of age on circulating immunoreactive and bioactive parathyroid hormone levels in women.

Authors:  M S Forero; R F Klein; R A Nissenson; K Nelson; H Heath; C D Arnaud; B L Riggs
Journal:  J Bone Miner Res       Date:  1987-10       Impact factor: 6.741

9.  Age-related rise in parathyroid hormone in man: the use of intact and midmolecule antisera to distinguish hormone secretion from retention.

Authors:  G Young; R Marcus; J R Minkoff; L Y Kim; G V Segre
Journal:  J Bone Miner Res       Date:  1987-10       Impact factor: 6.741

Review 10.  Perspective. How many women have osteoporosis?

Authors:  L J Melton; E A Chrischilles; C Cooper; A W Lane; B L Riggs
Journal:  J Bone Miner Res       Date:  1992-09       Impact factor: 6.741

View more
  12 in total

1.  Descriptive study of nursing home residents from the REHPA network.

Authors:  Y Rolland; G Abellan van Kan; S Hermabessiere; S Gerard; S Guyonnet Gillette; B Vellas
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

Review 2.  Prevention of secondary hyperparathyroidism and hip fracture in elderly women with calcium and vitamin D3 supplements.

Authors:  M C Chapuy; P J Meunier
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 3.  Vitamin D insufficiency as a determinant of hip fractures.

Authors:  J M Quesada-Gómez; J Alonso; R Bouillon
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

4.  Acute effects induced by a calcium-rich mineral water on calcium metabolism and on parathyroid function.

Authors:  J Guillemant; H T Le; S Guillemant; A M Delabroise; M J Arnaud
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

5.  Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease.

Authors:  Astrid Fahrleitner-Pammer; Andrea Obernosterer; Ernst Pilger; Harald Dobnig; Hans Peter Dimai; Georg Leb; Stefan Kudlacek; Barbara M Obermayer-Pietsch
Journal:  Osteoporos Int       Date:  2004-07-31       Impact factor: 4.507

6.  Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older.

Authors:  J E P Rockell; C M Skeaff; S M Williams; T J Green
Journal:  Osteoporos Int       Date:  2006-07-11       Impact factor: 4.507

Review 7.  Clinical guidelines for the treatment of osteoporosis in Japan.

Authors:  T Fujita
Journal:  Calcif Tissue Int       Date:  1996       Impact factor: 4.333

8.  Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease.

Authors:  Astrid Fahrleitner; Harald Dobnig; Andrea Obernosterer; Ernst Pilger; Georg Leb; Kurt Weber; Stefan Kudlacek; Barbara M Obermayer-Pietsch
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

9.  Association between vitamin D and bone mineral density in Iranian postmenopausal women.

Authors:  Farhad Hosseinpanah; Mehdi Rambod; Arash Hossein-nejad; Bagher Larijani; Fereidoun Azizi
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

Review 10.  The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report.

Authors:  S Boonen; R Rizzoli; P J Meunier; M Stone; G Nuki; U Syversen; M Lehtonen-Veromaa; P Lips; O Johnell; J-Y Reginster
Journal:  Osteoporos Int       Date:  2004-07       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.